Cisterna Bio will present preclinical mouse data on SPECC mRNA at the 14th International mRNA Health Conference, held November 17 to 19, 2026 at the Westin Copley Place in Boston. The company will introduce its SPEcific Capture and Cleavage (SPECC) platform that produces durable mRNAs of exceptional molecular purity.
Heat makes RNA easier to analyze and is essential to several manufacturing steps. In the wrong reaction mixture it also cleaves the backbone. Why temperature, time, pH, and free magnesium together decide whether you unfold your RNA or destroy it.
Cisterna Biologics has successfully completed an NSF SBIR Phase I project, demonstrating for the first time that yeast-engineered mRNA can be selectively purified and can drive protein expression in human cells, laying the groundwork for a scalable and cost-effective approach to non-immunogenic mRNA manufacturing.
We're excited to launch Cisterna's blog, a space for RNA researchers, scientists, and biotech enthusiasts to explore the science, applications, and latest developments in RNA research.